+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioMarin Pharmaceutical Inc. - logo

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. They are leaders in metabolic disease innovation with multiple products commercialized and a pipeline of product candidates to address unmet medical needs. BioMarin's headquarters are based in Novato, California, United States.

Hemophilia Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hemophilia Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 98 Pages
  • Global
From
Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update - Product Thumbnail Image

Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • Report
  • December 2023
  • 670 Pages
  • Global
From
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2030

  • Report
  • December 2021
  • 134 Pages
  • Global
From
Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type (Gaucher's Diseases, Fabry Diseases, Mucopolysaccharidosis, Pompe's Syndrome), By Type of Therapy By End User, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type (Gaucher's Diseases, Fabry Diseases, Mucopolysaccharidosis, Pompe's Syndrome), By Type of Therapy By End User, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • August 2022
  • 230 Pages
  • Global
From
Pompe Disease Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028 - Product Thumbnail Image

Pompe Disease Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

  • Report
  • July 2022
  • 100 Pages
  • Global
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Europe Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type (Gaucher's Diseases, Fabry Diseases, Mucopolysaccharidosis, Pompe's Syndrome), By Type of Therapy By End User, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type (Gaucher's Diseases, Fabry Diseases, Mucopolysaccharidosis, Pompe's Syndrome), By Type of Therapy By End User, By Country and Growth Forecast, 2022 - 2028

  • Report
  • August 2022
  • 91 Pages
  • Europe
From
North America Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type (Gaucher's Diseases, Fabry Diseases, Mucopolysaccharidosis, Pompe's Syndrome), By Type of Therapy By End User, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type (Gaucher's Diseases, Fabry Diseases, Mucopolysaccharidosis, Pompe's Syndrome), By Type of Therapy By End User, By Country and Growth Forecast, 2022 - 2028

  • Report
  • August 2022
  • 81 Pages
  • North America
From
LAMEA Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type (Gaucher's Diseases, Fabry Diseases, Mucopolysaccharidosis, Pompe's Syndrome), By Type of Therapy By End User, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type (Gaucher's Diseases, Fabry Diseases, Mucopolysaccharidosis, Pompe's Syndrome), By Type of Therapy By End User, By Country and Growth Forecast, 2022 - 2028

  • Report
  • August 2022
  • 91 Pages
  • Middle East, Africa
From
Asia Pacific Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type (Gaucher's Diseases, Fabry Diseases, Mucopolysaccharidosis, Pompe's Syndrome), By Type of Therapy By End User, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Lysosomal Disease Treatment Market Size, Share & Industry Trends Analysis Report By Disease Type (Gaucher's Diseases, Fabry Diseases, Mucopolysaccharidosis, Pompe's Syndrome), By Type of Therapy By End User, By Country and Growth Forecast, 2022 - 2028

  • Report
  • August 2022
  • 91 Pages
  • Asia Pacific
From
Pompe Disease Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Pompe Disease Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2022
  • 82 Pages
  • Global
From
Gaucher Disease Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Gaucher Disease Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2022
  • 95 Pages
  • Global
From
Lysosomal Storage Diseases Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Lysosomal Storage Diseases Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2022
  • 95 Pages
  • Global
From
Achondroplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Achondroplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 61 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency (A1AD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency (A1AD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 124 Pages
  • Global
From
BioMarin Pharmaceutical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

BioMarin Pharmaceutical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Biomarin 2023 Full Year Operating and Financial Review - SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Biotechnology Industry - Product Thumbnail Image

Biomarin 2023 Full Year Operating and Financial Review - SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Biotechnology Industry

  • SWOT Analysis
  • December 2023
  • Global
From
BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • May 2024
  • 59 Pages
From
Comprehensive Report on BioMarin Pharmaceutical Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on BioMarin Pharmaceutical Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis - Product Thumbnail Image

BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis

  • SWOT Analysis
  • January 2024
  • 47 Pages
From
Loading Indicator